{ "version": "2.2", "instance": { "pbm-20240131xf1a.htm": { "nsprefix": "pbm", "nsuri": "http://www.psyence.com/20240131", "dts": { "schema": { "local": [ "pbm-20240131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "pbm-20240131_cal.xml" ] }, "definitionLink": { "local": [ "pbm-20240131_def.xml" ] }, "labelLink": { "local": [ "pbm-20240131_lab.xml" ] }, "presentationLink": { "local": [ "pbm-20240131_pre.xml" ] }, "inline": { "local": [ "pbm-20240131xf1a.htm" ] } }, "keyStandard": 115, "keyCustom": 72, "axisStandard": 15, "axisCustom": 2, "memberStandard": 17, "memberCustom": 29, "hidden": { "total": 9, "http://xbrl.sec.gov/dei/2023": 3, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 2, "http://www.psyence.com/20240131": 4 }, "contextCount": 113, "entityCount": 1, "segmentCount": 49, "elementCount": 337, "unitCount": 9, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 362, "http://xbrl.sec.gov/dei/2023": 7 }, "report": { "R1": { "role": "http://www.psyence.com/role/DocumentDocumentAndEntityInformation", "longName": "100090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "longName": "100100 - Statement - Condensed Carve out Consolidated Interim Statements of Financial Position", "shortName": "Condensed Carve out Consolidated Interim Statements of Financial Position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R3": { "role": "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "longName": "100200 - Statement - Condensed Carve out Consolidated Interim Statements of Net Loss and Comprehensive Loss", "shortName": "Condensed Carve out Consolidated Interim Statements of Net Loss and Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_1_31_2023_ZPTmVzYfUkuQ7lOWzw4V4A", "name": "ifrs-full:SalesAndMarketingExpense", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:IfrsOperatingIncomeLoss", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R4": { "role": "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "longName": "100300 - Statement - Condensed Carve out Consolidated Interim Statements of Change in Shareholder Equity", "shortName": "Condensed Carve out Consolidated Interim Statements of Change in Shareholder Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "As_Of_3_31_2021_JcF11DXeMUSpkD6XRSZfYA", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_1_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gzuZ3JLL1UeWUJCw-7v-uQ", "name": "ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R5": { "role": "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "longName": "100400 - Statement - Condensed Carve out Consolidated Interim Statements of Cash Flows", "shortName": "Condensed Carve out Consolidated Interim Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:ProfitLoss", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R6": { "role": "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcern", "longName": "110101 - Disclosure - Nature of operations and going concern", "shortName": "Nature of operations and going concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R7": { "role": "http://www.psyence.com/role/DisclosureBasisOfPresentation", "longName": "110201 - Disclosure - Basis of presentation", "shortName": "Basis of presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://www.psyence.com/role/DisclosureMaterialAccountingPolicies", "longName": "110301 - Disclosure - Material accounting policies", "shortName": "Material accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://www.psyence.com/role/DisclosureCriticalAccountingEstimatesAndJudgements", "longName": "110401 - Disclosure - Critical accounting estimates and judgements", "shortName": "Critical accounting estimates and judgements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R10": { "role": "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcac", "longName": "110501 - Disclosure - Reverse takeover transaction with NCAC", "shortName": "Reverse takeover transaction with NCAC", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ReverseTakeoverTransactionWithNcacTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ReverseTakeoverTransactionWithNcacTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalents", "longName": "110601 - Disclosure - Cash, restricted cash and cash equivalents", "shortName": "Cash, restricted cash and cash equivalents", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:CashRestrictedCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R12": { "role": "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilities", "longName": "110701 - Disclosure - Accounts payable and accrued liabilities", "shortName": "Accounts payable and accrued liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:AccountsPayableAndAccruedLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R13": { "role": "http://www.psyence.com/role/DisclosureConvertibleNoteLiability", "longName": "110801 - Disclosure - Convertible note liability", "shortName": "Convertible note liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:DisclosureOfConvertibleNoteLiabilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:DisclosureOfConvertibleNoteLiabilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilities", "longName": "110901 - Disclosure - Derivative warrant liabilities", "shortName": "Derivative warrant liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.psyence.com/role/DisclosurePromissoryNotes", "longName": "111001 - Disclosure - Promissory Notes", "shortName": "Promissory Notes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:PromissoryNotesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:PromissoryNotesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.psyence.com/role/DisclosureShareCapital", "longName": "111101 - Disclosure - Share capital", "shortName": "Share capital", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.psyence.com/role/DisclosureOtherIncome", "longName": "111201 - Disclosure - Other income", "shortName": "Other income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.psyence.com/role/DisclosureCapitalManagement", "longName": "111301 - Disclosure - Capital management", "shortName": "Capital management", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:CapitalManagementDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R19": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedParties", "longName": "111401 - Disclosure - Transactions with related parties", "shortName": "Transactions with related parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R20": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensation", "longName": "111501 - Disclosure - Share based compensation", "shortName": "Share based compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R21": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagement", "longName": "111601 - Disclosure - Financial instruments and financial risk management", "shortName": "Financial instruments and financial risk management", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R22": { "role": "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "longName": "120302 - Disclosure - Material accounting policies (Policies)", "shortName": "Material accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R23": { "role": "http://www.psyence.com/role/DisclosureBasisOfPresentationTables", "longName": "130203 - Disclosure - Basis of presentation (Tables)", "shortName": "Basis of presentation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R24": { "role": "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacTables", "longName": "130503 - Disclosure - Reverse takeover transaction with NCAC (Tables)", "shortName": "Reverse takeover transaction with NCAC (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ScheduleOfListingExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ScheduleOfListingExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsTables", "longName": "130603 - Disclosure - Cash, restricted cash and cash equivalents (Tables)", "shortName": "Cash, restricted cash and cash equivalents (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "pbm:CashRestrictedCashAndCashEquivalentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R26": { "role": "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesTables", "longName": "130703 - Disclosure - Accounts payable and accrued liabilities (Tables)", "shortName": "Accounts payable and accrued liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "pbm:AccountsPayableAndAccruedLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesTables", "longName": "130903 - Disclosure - Derivative warrant liabilities (Tables)", "shortName": "Derivative warrant liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesTables", "longName": "131403 - Disclosure - Transactions with related parties (Tables)", "shortName": "Transactions with related parties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R29": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensationTables", "longName": "131503 - Disclosure - Share based compensation (Tables)", "shortName": "Share based compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementTables", "longName": "131603 - Disclosure - Financial instruments and financial risk management (Tables)", "shortName": "Financial instruments and financial risk management (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "longName": "140101 - Disclosure - Nature of operations and going concern (Details)", "shortName": "Nature of operations and going concern (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:IfrsProceedsFromConvertibleDebt", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_23_2024_ifrs-full_BusinessCombinationsAxis_pbm_BusinessCombinationAgreementWithNewcourtAcquisitionCorp.Member_PtSy1Yco9Eqnmof9uY4Yyg", "name": "pbm:ThresholdAmountForMinimumCashCondition", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "pbm:ThresholdAmountForMinimumCashCondition", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R32": { "role": "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "longName": "140201 - Disclosure - Basis of presentation (Details)", "shortName": "Basis of presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_pbm_PsyenceAustraliaPtyLtd.Member_k4P4g4THzkmgyZamysexpg", "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_pbm_PysenceBiomedIICorpMember__C-rjKslF0OlWKw_iMsBMw", "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R33": { "role": "http://www.psyence.com/role/DisclosureCriticalAccountingEstimatesAndJudgementsDetails", "longName": "140401 - Disclosure - Critical accounting estimates and judgements (Details)", "shortName": "Critical accounting estimates and judgements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "As_Of_1_26_2024_t9WYqypqp06zQcG3lwQ9kg", "name": "pbm:IfrsSharePrice", "unitRef": "Unit_Divide_USD_shares_DWhNSHM79Uun66hWdA46BQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R34": { "role": "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "longName": "140501 - Disclosure - Reverse takeover transaction with NCAC (Details)", "shortName": "Reverse takeover transaction with NCAC (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "As_Of_1_26_2024_t9WYqypqp06zQcG3lwQ9kg", "name": "pbm:IfrsSharePrice", "unitRef": "Unit_Divide_USD_shares_DWhNSHM79Uun66hWdA46BQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R35": { "role": "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "longName": "140502 - Disclosure - Reverse takeover transaction with NCAC - listing expenses (Details)", "shortName": "Reverse takeover transaction with NCAC - listing expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "As_Of_1_26_2024_t9WYqypqp06zQcG3lwQ9kg", "name": "pbm:IfrsSharePrice", "unitRef": "Unit_Divide_USD_shares_DWhNSHM79Uun66hWdA46BQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_pbm_ReverseTakeoverTransactionWithNcacAxis_pbm_NcacMember_p3r7BFd3r0WOD1WUBBef3Q", "name": "pbm:StockIssuedDuringPeriodSharesIssuedForReverseTakeoverTransaction", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "pbm:ScheduleOfListingExpensesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R36": { "role": "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacAdditionalInformationDetails", "longName": "140503 - Disclosure - Reverse takeover transaction with NCAC - Additional information (Details)", "shortName": "Reverse takeover transaction with NCAC - Additional information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:TransactionExpense", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R37": { "role": "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetails", "longName": "140601 - Disclosure - Cash, restricted cash and cash equivalents (Details)", "shortName": "Cash, restricted cash and cash equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:BalancesWithBanks", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "pbm:CashRestrictedCashAndCashEquivalentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R38": { "role": "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "longName": "140701 - Disclosure - Accounts payable and accrued liabilities (Details)", "shortName": "Accounts payable and accrued liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "pbm:ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock", "pbm:AccountsPayableAndAccruedLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R39": { "role": "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "longName": "140801 - Disclosure - Convertible note liability (Details)", "shortName": "Convertible note liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:IfrsProceedsFromConvertibleDebt", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_25_2024_To_1_25_2024_SGpdm6g_-EuTMN_xl53zKg", "name": "pbm:NumberOfDaysPriorToEffectiveInitialRegistrationStatementForFirstResetDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "pbm:DisclosureOfConvertibleNoteLiabilityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R40": { "role": "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "longName": "140901 - Disclosure - Derivative warrant liabilities (Details)", "shortName": "Derivative warrant liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:NumberOfClassesOfWarrantsOutstanding", "unitRef": "Unit_Standard_item_c1KXcWq1jk6xFW89P53aoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:NumberOfClassesOfWarrantsOutstanding", "unitRef": "Unit_Standard_item_c1KXcWq1jk6xFW89P53aoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "longName": "140902 - Disclosure - Derivative warrant liabilities - Fair value measurements (Details)", "shortName": "Derivative warrant liabilities - Fair value measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R42": { "role": "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails", "longName": "140903 - Disclosure - Derivative warrant liabilities - Warrant transactions (Details)", "shortName": "Derivative warrant liabilities - Warrant transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "pbm:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "unitRef": "Unit_Divide_USD_shares_DWhNSHM79Uun66hWdA46BQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_ifrs-full_ClassesOfFinancialInstrumentsAxis_pbm_PublicWarrantsMember_zCpmyl3DqkeeidTzxwd3rQ", "name": "pbm:WarrantsIssuedNumber", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "pbm:ScheduleOfWarrantTransactionsAndNumberOfWarrantsOutstandingTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R43": { "role": "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "longName": "140904 - Disclosure - Derivative warrant liabilities - Outstanding and exercisable (Details)", "shortName": "Derivative warrant liabilities - Outstanding and exercisable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "pbm:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "unitRef": "Unit_Divide_USD_shares_DWhNSHM79Uun66hWdA46BQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "pbm:NumberOfWarrantsExercisable", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "pbm:ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R44": { "role": "http://www.psyence.com/role/DisclosurePromissoryNotesDetails", "longName": "141001 - Disclosure - Promissory Notes (Details)", "shortName": "Promissory Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_1_31_2024_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_ParentMember_-PZfZUge4U6oECu_d4s9WA", "name": "ifrs-full:CurrentDebtInstrumentsIssued", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_25_2024_ifrs-full_BorrowingsByNameAxis_pbm_UnsecuredConvertiblePromissoryNotesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_ParentMember_p53ehRl5kESduKdEPr_oAw", "name": "ifrs-full:NotionalAmount", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "pbm:PromissoryNotesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R45": { "role": "http://www.psyence.com/role/DisclosureShareCapitalDetails", "longName": "141101 - Disclosure - Share capital (Details)", "shortName": "Share capital (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.psyence.com/role/DisclosureOtherIncomeDetails", "longName": "141201 - Disclosure - Other income (Details)", "shortName": "Other income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_8_21_2023_ifrs-full_BorrowingsByNameAxis_pbm_LoanFromRhCapitalFinanceCo.LlcMember_juDt_dFha0CK0QB0z-J3Eg", "name": "ifrs-full:NotionalAmount", "unitRef": "Unit_Standard_AUD_NgPxxaJIAk-oLUKsB7NTxA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_8_21_2023_ifrs-full_BorrowingsByNameAxis_pbm_LoanFromRhCapitalFinanceCo.LlcMember_juDt_dFha0CK0QB0z-J3Eg", "name": "ifrs-full:NotionalAmount", "unitRef": "Unit_Standard_AUD_NgPxxaJIAk-oLUKsB7NTxA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetails", "longName": "141401 - Disclosure - Transactions with related parties - Key Management Personnel (Details)", "shortName": "Transactions with related parties - Key Management Personnel (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R48": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensationDetails", "longName": "141501 - Disclosure - Share based compensation (Details)", "shortName": "Share based compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails", "longName": "141601 - Disclosure - Financial instruments and financial risk management - Carrying Value of the Financial Instruments (Details)", "shortName": "Financial instruments and financial risk management - Carrying Value of the Financial Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_31_2024_ifrs-full_ClassesOfFinancialLiabilitiesAxis_pbm_WarrantLiabilitiesMember_pbm_IfrsClassOfWarrantOrRightAxis_pbm_PrivateWarrantsMember_4pt6W0lJQE678sYizNOgwA", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R50": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "longName": "141602 - Disclosure - Financial instruments and financial risk management - Maturity of the Contractual Obligations (Details)", "shortName": "Financial instruments and financial risk management - Maturity of the Contractual Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "pbm:ScheduleOfMaturityAnalysisOfFinancialLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "pbm:ScheduleOfMaturityAnalysisOfFinancialLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetails", "longName": "141603 - Disclosure - Financial instruments and financial risk management (Details)", "shortName": "Financial instruments and financial risk management (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "pbm:PercentageOfReasonablyPossibleChangeInRiskAssumption", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition", "longName": "200100 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Uncategorized", "order": "52", "firstAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R53": { "role": "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss", "longName": "200200 - Statement - CONSOLIDATED STATEMENTS OF NET LOSS AND COMPREHENSIVE LOSS", "shortName": "CONSOLIDATED STATEMENTS OF NET LOSS AND COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "53", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_1_31_2023_ZPTmVzYfUkuQ7lOWzw4V4A", "name": "ifrs-full:SalesAndMarketingExpense", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:SalesAndMarketingExpense", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R54": { "role": "http://www.psyence.com/role/StatementConsolidatedStatementsOfChangesInNetParentInvestment", "longName": "200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN NET PARENT INVESTMENT", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN NET PARENT INVESTMENT", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "54", "firstAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "55", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:ProfitLoss", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:AdjustmentsForSharebasedPayments", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R56": { "role": "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcerns", "longName": "210101 - Disclosure - Nature of operations and going concern", "shortName": "Nature of operations and going concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "56", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R57": { "role": "http://www.psyence.com/role/DisclosureBasisOfPresentations", "longName": "210201 - Disclosure - Basis of presentation", "shortName": "Basis of presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "57", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R58": { "role": "http://www.psyence.com/role/DisclosureSignificantAccountingPolicies", "longName": "210301 - Disclosure - Significant accounting policies", "shortName": "Significant accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "58", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R59": { "role": "http://www.psyence.com/role/DisclosureCriticalAccountingEstimatesAndJudgementss", "longName": "210401 - Disclosure - Critical accounting estimates and judgements", "shortName": "Critical accounting estimates and judgements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "59", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R60": { "role": "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentss", "longName": "210501 - Disclosure - Cash, restricted cash and cash equivalents", "shortName": "Cash, restricted cash and cash equivalents", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "60", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:CashRestrictedCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R61": { "role": "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiess", "longName": "210601 - Disclosure - Accounts payable and accrued liabilities", "shortName": "Accounts payable and accrued liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "61", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:AccountsPayableAndAccruedLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R62": { "role": "http://www.psyence.com/role/DisclosureIncomeTaxes", "longName": "210701 - Disclosure - Income taxes", "shortName": "Income taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "62", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.psyence.com/role/DisclosureCapitalManagements", "longName": "210801 - Disclosure - Capital management", "shortName": "Capital management", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "63", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:CapitalManagementDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R64": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiess", "longName": "210901 - Disclosure - Transactions with related parties", "shortName": "Transactions with related parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "64", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R65": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensations", "longName": "211001 - Disclosure - Share based compensation", "shortName": "Share based compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "65", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R66": { "role": "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroup", "longName": "211101 - Disclosure - Advances from Psyence Group", "shortName": "Advances from Psyence Group", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "66", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:DisclosureOfAdvancesFromParentExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:DisclosureOfAdvancesFromParentExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagements", "longName": "211201 - Disclosure - Financial instruments and financial risk management", "shortName": "Financial instruments and financial risk management", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "67", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R68": { "role": "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies", "longName": "220302 - Disclosure - Significant accounting policies (Policies)", "shortName": "Significant accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "68", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:DescriptionOfAccountingPolicyForNetParentInvestmentPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R69": { "role": "http://www.psyence.com/role/DisclosureBasisOfPresentationTabless", "longName": "230203 - Disclosure - Basis of presentation (Tables)", "shortName": "Basis of presentation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "69", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R70": { "role": "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsTabless", "longName": "230503 - Disclosure - Cash, restricted cash and cash equivalents (Tables)", "shortName": "Cash, restricted cash and cash equivalents (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "70", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "pbm:CashRestrictedCashAndCashEquivalentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R71": { "role": "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesTabless", "longName": "230603 - Disclosure - Accounts payable and accrued liabilities (Tables)", "shortName": "Accounts payable and accrued liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "71", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "pbm:AccountsPayableAndAccruedLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R72": { "role": "http://www.psyence.com/role/DisclosureIncomeTaxesTables", "longName": "230703 - Disclosure - Income taxes (Tables)", "shortName": "Income taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "72", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesTabless", "longName": "230903 - Disclosure - Transactions with related parties (Tables)", "shortName": "Transactions with related parties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "73", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R74": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensationTabless", "longName": "231003 - Disclosure - Share based compensation (Tables)", "shortName": "Share based compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "74", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R75": { "role": "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroupTables", "longName": "231103 - Disclosure - Advances from Psyence Group (Tables)", "shortName": "Advances from Psyence Group (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "75", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:DisclosureOfAdvancesFromRepaymentsToParentExplanatoryTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "pbm:DisclosureOfAdvancesFromParentExplanatoryTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:DisclosureOfAdvancesFromRepaymentsToParentExplanatoryTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "pbm:DisclosureOfAdvancesFromParentExplanatoryTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetailss", "longName": "240101 - Disclosure - Nature of operations and going concern (Details)", "shortName": "Nature of operations and going concern (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "pbm:ClinicalTrialsNumberOfPatientsToParticipate", "unitRef": "Unit_Standard_item_c1KXcWq1jk6xFW89P53aoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss", "longName": "240201 - Disclosure - Basis of presentation (Details)", "shortName": "Basis of presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_pbm_PsyenceAustraliaPtyLtd.Member_k4P4g4THzkmgyZamysexpg", "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R78": { "role": "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss", "longName": "240501 - Disclosure - Cash, restricted cash and cash equivalents (Details)", "shortName": "Cash, restricted cash and cash equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:BalancesWithBanks", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "pbm:CashRestrictedCashAndCashEquivalentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R79": { "role": "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetailss", "longName": "240601 - Disclosure - Accounts payable and accrued liabilities (Details)", "shortName": "Accounts payable and accrued liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "pbm:ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock", "pbm:AccountsPayableAndAccruedLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R80": { "role": "http://www.psyence.com/role/DisclosureIncomeTaxesDetails", "longName": "240701 - Disclosure - Income taxes (Details)", "shortName": "Income taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails", "longName": "240702 - Disclosure - Income taxes - Unrecognized deferred tax asset (Details)", "shortName": "Income taxes - Unrecognized deferred tax asset (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails", "longName": "240703 - Disclosure - Income taxes - Non-capital income tax losses (Details)", "shortName": "Income taxes - Non-capital income tax losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "pbm:SummaryOfNonCapitalIncomeTaxLossesTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "pbm:SummaryOfNonCapitalIncomeTaxLossesTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R83": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss", "longName": "240901 - Disclosure - Transactions with related parties - Key Management Personnel (Details)", "shortName": "Transactions with related parties - Key Management Personnel (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R84": { "role": "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesDetails", "longName": "240902 - Disclosure - Transactions with related parties (Details)", "shortName": "Transactions with related parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2023_Zb9FxF1D7kCMDSHfsDItRA", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R85": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensationDetailss", "longName": "241001 - Disclosure - Share based compensation (Details)", "shortName": "Share based compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "Duration_4_1_2023_To_1_31_2024_KiqF6mru-E6uwZsZYqa9sA", "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "unitRef": "Unit_Standard_USD_kRgu8zcCZky8ehaX6rHbmQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null }, "R86": { "role": "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails", "longName": "241002 - Disclosure - Share based compensation - Weighted average assumptions (Details)", "shortName": "Share based compensation - Weighted average assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement", "unitRef": "Unit_Standard_shares_9Wk6InEgEEGJiYgONCHjEA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroupDetails", "longName": "241101 - Disclosure - Advances from Psyence Group (Details)", "shortName": "Advances from Psyence Group (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "Duration_4_1_2022_To_3_31_2023_75g76qd3akiQN0EJVDajKg", "name": "pbm:AmountsAdvancedFromToParent", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2021_JcF11DXeMUSpkD6XRSZfYA", "name": "pbm:AdvancesFromParent", "unitRef": "Unit_Standard_CAD_yydI11cMp0CBErs4jQPduQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "pbm:DisclosureOfAdvancesFromRepaymentsToParentExplanatoryTableTextBlock", "pbm:DisclosureOfAdvancesFromParentExplanatoryTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "unique": true } }, "R88": { "role": "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetailss", "longName": "241201 - Disclosure - Financial instruments and financial risk management (Details)", "shortName": "Financial instruments and financial risk management (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "As_Of_1_31_2024_IOyzUovC7EqfoWKU9Pq-Eg", "name": "pbm:PercentageOfReasonablyPossibleChangeInRiskAssumption", "unitRef": "Unit_Standard_pure_byoig0RriUGxjMdUHcCOVw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pbm-20240131xf1a.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "calculation": { "http://www.psyence.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting profit", "terseLabel": "Net Loss before recovery of income taxes" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r26", "r27" ] }, "pbm_AccountsPayableAndAccruedLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AccountsPayableAndAccruedLiabilitiesTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilities", "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiess" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Text Block]", "terseLabel": "Accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "ifrs-full_AccrualsClassifiedAsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccrualsClassifiedAsCurrent", "crdr": "credit", "calculation": { "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetailss" ], "lang": { "en-us": { "role": { "label": "Accruals classified as current", "terseLabel": "Accrued liabilities" } }, "en": { "role": { "documentation": "The amount of accruals classified as current. [Refer: Accruals]" } } }, "auth_ref": [ "r149" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share", "terseLabel": "Weighted average number of outstanding shares - diluted (in shares)" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r50" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in other operating receivables", "terseLabel": "Other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r154" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in prepaid expenses", "terseLabel": "Prepaids" } }, "en": { "role": { "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]" } } }, "auth_ref": [ "r156" ] }, "pbm_AdjustmentsForIncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AdjustmentsForIncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for increase (decrease) in accounts payable and accrued liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "pbm_AdjustmentsForListingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AdjustmentsForListingExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for listing expense to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Listing Expense", "terseLabel": "Listing expense" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile profit (loss) [abstract]", "terseLabel": "Non-cash adjustment:" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share based compensation" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r155" ] }, "pbm_AdjustmentsForTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AdjustmentsForTransactionExpenses", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Transaction Expenses", "terseLabel": "Transaction expenses" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for unrealised foreign exchange losses (gains)", "terseLabel": "Foreign exchange" } }, "en": { "role": { "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r125", "r155" ] }, "pbm_AdvancesFromParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AdvancesFromParent", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroupDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of advances from the Company's parent, classified as part of the Company's net parent investment.", "label": "Advances From Parent", "periodEndLabel": "Advances from (repayments to) Psyence Group, Ending balance", "periodStartLabel": "Advances from (repayments to) Psyence Group, Opening balance" } } }, "auth_ref": [] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "label": "Aggregated time bands [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r12", "r77", "r78", "r79", "r80", "r81", "r82", "r83", "r94", "r123", "r138", "r140" ] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "All levels of fair value hierarchy [member]", "terseLabel": "All levels of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r31", "r72" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "pbm_AmountsAdvancedFromRepaidToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AmountsAdvancedFromRepaidToParent", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroupDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of advances received from and (repayments made to) the Company's parent during the period.", "label": "Amounts Advanced From (Repaid To) Parent", "terseLabel": "Amounts advanced (repaid)" } } }, "auth_ref": [] }, "pbm_AmountsAdvancedFromToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "AmountsAdvancedFromToParent", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroupDetails", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of advances received from and (repayments made to) the Company's parent during the period, classified as financing activities.", "label": "Amounts Advanced From/(to) Parent", "terseLabel": "Amounts advanced from/(to) parent", "verboseLabel": "Cash advances from Psyence Group" } } }, "auth_ref": [] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Amounts payable, related party transactions", "terseLabel": "Accounts payable to related parties" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r37", "r40" ] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Applicable tax rate", "terseLabel": "Statutory income tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "TOTAL ASSETS" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r10", "r71", "r72", "r74", "r106", "r108" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets [abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "ifrs-full_BalancesWithBanks": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BalancesWithBanks", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss": { "parentTag": "pbm_CashRestrictedCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetails", "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss" ], "lang": { "en-us": { "role": { "label": "Balances with banks", "terseLabel": "Unrestricted cash held with chartered banks" } }, "en": { "role": { "documentation": "The amount of cash balances held at banks." } } }, "auth_ref": [ "r157" ] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share", "terseLabel": "Loss per share - basic (in dollars per share)" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r48", "r49" ] }, "pbm_BasisOfPresentationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "BasisOfPresentationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Basis of presentation" } } }, "auth_ref": [] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Borrowings", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings", "negatedLabel": "NCAC promissory note (Note 10)" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r148" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureOtherIncomeDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]", "terseLabel": "IFRS Debt Instrument [Axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r160" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureOtherIncomeDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [member]", "terseLabel": "IFRS Debt Instrument, Name [Domain]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r160" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureOtherIncomeDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate", "terseLabel": "Interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r160" ] }, "pbm_BorrowingsMinimumInterestChargeablePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "BorrowingsMinimumInterestChargeablePeriod", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum interest chargeable period of borrowings in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Borrowings, Minimum Interest Chargeable Period", "terseLabel": "Minimum interest chargeable period" } } }, "auth_ref": [] }, "pbm_BorrowingsPeriodToRepayAfterNoticeOfAssessment": { "xbrltype": "durationItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "BorrowingsPeriodToRepayAfterNoticeOfAssessment", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "The period to repay the borrowings after the notice assessment received related to the research and development refunds.", "label": "Borrowings, Period To Repay After Notice Of Assessment", "terseLabel": "Repayment period after notice of assessment" } } }, "auth_ref": [] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]", "terseLabel": "Minimum" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r76", "r82", "r86", "r130", "r131", "r160" ] }, "pbm_BusinessCombinationAgreementWithNewcourtAcquisitionCorp.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "BusinessCombinationAgreementWithNewcourtAcquisitionCorp.Member", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Business Combination Agreement with Newcourt Acquisition Corp.", "label": "Business Combination Agreement With Newcourt Acquisition Corp. [Member]", "terseLabel": "Business combination agreement" } } }, "auth_ref": [] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r92" ] }, "pbm_CapitalManagementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "CapitalManagementAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Capital management" } } }, "auth_ref": [] }, "pbm_CapitalManagementDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "CapitalManagementDisclosureTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureCapitalManagement", "http://www.psyence.com/role/DisclosureCapitalManagements" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on capital management.", "label": "Capital Management Disclosure [Text Block]", "terseLabel": "Capital management" } } }, "auth_ref": [] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period", "terseLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r8", "r55", "r68" ] }, "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) decrease (increase) in restricted cash and cash equivalents", "terseLabel": "Decrease in restricted cash", "verboseLabel": "Increase in restricted cash" } }, "en": { "role": { "documentation": "The cash inflow (outflow) due to a decrease (increase) in restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]" } } }, "auth_ref": [ "r152" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Cash provided from financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r53", "r57" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Cash provided from investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r53", "r57" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Cash used in operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r53", "r57" ] }, "pbm_CashRestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "CashRestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetails", "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash, restricted cash and cash equivalents.", "label": "Cash, Restricted Cash and Cash Equivalents, Total", "terseLabel": "Total", "totalLabel": "Total" } } }, "auth_ref": [] }, "pbm_CashRestrictedCashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "CashRestrictedCashAndCashEquivalentsAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Cash, restricted cash and cash equivalents" } } }, "auth_ref": [] }, "pbm_CashRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "CashRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalents", "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentss" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on cash, restricted cash and cash equivalents.", "label": "Cash, Restricted Cash and Cash Equivalents [Text Block]", "terseLabel": "Cash, restricted cash and cash equivalents" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails", "http://www.psyence.com/role/DisclosureShareCapitalDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]", "terseLabel": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r39" ] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [axis]", "terseLabel": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r97", "r98", "r99", "r100" ] }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Financial instruments, class [member]", "terseLabel": "Financial instruments, class [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r97", "r98", "r99", "r100" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r102", "r103", "r113", "r114" ] }, "pbm_ClinicalTrialsNumberOfPatientsToParticipate": { "xbrltype": "integerItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ClinicalTrialsNumberOfPatientsToParticipate", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetailss" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of patients to participate in the study for clinical trials.", "label": "Clinical Trials, Number of Patients to Participate", "terseLabel": "Number of patients to participate in the study for clinical trials" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]", "terseLabel": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r4" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetailss", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Comprehensive income", "negatedTotalLabel": "TOTAL COMPREHENSIVE LOSS", "terseLabel": "Comprehensive loss", "totalLabel": "TOTAL COMPREHENSIVE LOSS" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r0", "r21", "r59", "r61", "r66", "r127" ] }, "pbm_ConvertibleNoteLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ConvertibleNoteLiabilityAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Convertible note liability" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "auth_ref": [] }, "ifrs-full_CountryOfDomicileMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfDomicileMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Country of domicile [member]", "terseLabel": "Canada" } }, "en": { "role": { "documentation": "This member stands for the country in which the entity is registered and where it has its legal address or registered office." } } }, "auth_ref": [ "r110", "r111" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "pbm_CriticalAccountingEstimatesAndJudgementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "CriticalAccountingEstimatesAndJudgementsAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Critical accounting estimates and judgements" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r13", "r64", "r127" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets [abstract]", "terseLabel": "Current assets" } } }, "auth_ref": [] }, "ifrs-full_CurrentDebtInstrumentsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDebtInstrumentsIssued", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosurePromissoryNotesDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current debt instruments issued", "terseLabel": "Due to related party", "verboseLabel": "Promissory notes payable" } }, "en": { "role": { "documentation": "The amount of current debt instruments issued. [Refer: Debt instruments issued]" } } }, "auth_ref": [ "r148" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r14", "r65", "r127" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "terseLabel": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepayments", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 4.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current prepayments", "terseLabel": "Prepaids" } }, "en": { "role": { "documentation": "The amount of current prepayments. [Refer: Prepayments]" } } }, "auth_ref": [ "r119" ] }, "ifrs-full_CurrentRestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentRestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 }, "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss": { "parentTag": "pbm_CashRestrictedCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetails", "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current restricted cash and cash equivalents", "terseLabel": "Restricted cash", "verboseLabel": "Restricted Cash" } }, "en": { "role": { "documentation": "The amount of current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]" } } }, "auth_ref": [ "r148" ] }, "ifrs-full_CurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentWarrantLiability", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current warrant liability", "negatedLabel": "Derivative warrant liabilities (Note 9)", "terseLabel": "Derivative warrant liabilities" } }, "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r148" ] }, "pbm_DebtInstrumentConvertibleFloorPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DebtInstrumentConvertibleFloorPrice", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The floor price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible Floor Price", "terseLabel": "Conversion floor price" } } }, "auth_ref": [] }, "pbm_DebtInstrumentConvertibleInitialConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DebtInstrumentConvertibleInitialConversionPrice", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Initial Conversion Price", "terseLabel": "Initial Conversion Price" } } }, "auth_ref": [] }, "pbm_DebtIssuedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DebtIssuedMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to debt issued.", "label": "Debt Issued [Member]", "terseLabel": "Debt Issued" } } }, "auth_ref": [] }, "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Deductible temporary differences for which no deferred tax asset is recognised", "terseLabel": "Unrecognized deferred tax asset" } }, "en": { "role": { "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r28" ] }, "pbm_DerivativeWarrantLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DerivativeWarrantLiabilitiesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Derivative warrant liabilities" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for earnings per share [text block]", "terseLabel": "Loss per share" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for earnings per share." } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for financial instruments [text block]", "terseLabel": "IFRS 9 Financial instruments", "verboseLabel": "Financial instruments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for foreign currency translation [text block]", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for income tax [text block]", "terseLabel": "Income taxes" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r147" ] }, "pbm_DescriptionOfAccountingPolicyForNetParentInvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DescriptionOfAccountingPolicyForNetParentInvestmentPolicyTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's material accounting policy information for net parent investment.", "label": "Description of Accounting Policy for Net Parent Investment [Policy Text Block]", "terseLabel": "Net parent investment" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for provisions [text block]", "terseLabel": "Provisions" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]" } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for research and development expense [text block]", "terseLabel": "Research and development" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for share-based payment transactions [text block]", "terseLabel": "Share based compensation" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for transactions with related parties [text block]", "terseLabel": "Related party transactions" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions with related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPoliciesPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]", "terseLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility, share options granted", "terseLabel": "Expected volatility" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r88" ] }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfOptionLifeShareOptionsGranted", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Option life, share options granted", "terseLabel": "Expected life" } }, "en": { "role": { "documentation": "The option life of share options granted." } } }, "auth_ref": [ "r88" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate, share options granted", "terseLabel": "Risk-free interest rate" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r88" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Loss per share - diluted (in dollars per share)" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r48", "r49" ] }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureCriticalAccountingEstimatesAndJudgements", "http://www.psyence.com/role/DisclosureCriticalAccountingEstimatesAndJudgementss" ], "lang": { "en-us": { "role": { "label": "Disclosure of accounting judgements and estimates [text block]", "terseLabel": "Critical accounting estimates and judgements" } }, "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r144" ] }, "pbm_DisclosureOfAdvancesFromParentExplanatoryAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfAdvancesFromParentExplanatoryAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Advances from Psyence Group" } } }, "auth_ref": [] }, "pbm_DisclosureOfAdvancesFromParentExplanatoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfAdvancesFromParentExplanatoryTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroup" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for advances from the Company's parent.", "label": "Disclosure Of Advances From Parent, Explanatory [Text Block]", "terseLabel": "Advances from Psyence Group" } } }, "auth_ref": [] }, "pbm_DisclosureOfAdvancesFromRepaymentsToParentExplanatoryTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfAdvancesFromRepaymentsToParentExplanatoryTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureAdvancesFromPsyenceGroupTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about advances from (repayments to) the Company's parent.", "label": "Disclosure Of Advances From (Repayments To) Parent, Explanatory [Table Text Block]", "terseLabel": "Schedule of advances from (repayments to) Psyence Group" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentation", "http://www.psyence.com/role/DisclosureBasisOfPresentations" ], "lang": { "en-us": { "role": { "label": "Disclosure of basis of preparation of financial statements [text block]", "terseLabel": "Basis of presentation" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBusinessCombinationsLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [abstract]", "terseLabel": "Nature of operations and going concern" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r92" ] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsTables", "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsTabless" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash and cash equivalents [text block]", "terseLabel": "Summary of cash and cash equivalents" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]", "terseLabel": "Share capital" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://www.psyence.com/role/DisclosureShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r18" ] }, "pbm_DisclosureOfConvertibleNoteLiabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfConvertibleNoteLiabilityTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiability" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of Convertible note liability.", "label": "Disclosure of Convertible Note Liability [Text Block]", "verboseLabel": "Convertible note liability" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilities" ], "lang": { "en-us": { "role": { "label": "Disclosure of derivative financial instruments [text block]", "terseLabel": "Derivative warrant liabilities" } }, "en": { "role": { "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]", "terseLabel": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r160" ] }, "pbm_DisclosureOfDetailedInformationAboutOtherIncomeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfDetailedInformationAboutOtherIncomeLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Disclosure Of Detailed Information About Other Income [Line Items]", "terseLabel": "Other income" } } }, "auth_ref": [] }, "pbm_DisclosureOfDetailedInformationAboutOtherIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfDetailedInformationAboutOtherIncomeTable", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to the other income.", "label": "Disclosure of Detailed Information About Other Income [Table]" } } }, "auth_ref": [] }, "pbm_DisclosureOfDetailedInformationAboutReverseTakeoverTransactionWithNcacLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfDetailedInformationAboutReverseTakeoverTransactionWithNcacLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Disclosure of Detailed Information About Reverse Takeover Transaction with NCAC [Line Items]", "terseLabel": "Reverse takeover transaction with NCAC" } } }, "auth_ref": [] }, "pbm_DisclosureOfDetailedInformationAboutReverseTakeoverTransactionWithNcacTable": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DisclosureOfDetailedInformationAboutReverseTakeoverTransactionWithNcacTable", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to reverse takeover transaction.", "label": "Disclosure of Detailed Information About Reverse Takeover Transaction with NCAC [Table]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [line items]", "terseLabel": "Financial instruments and financial risk management" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesTable", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of liabilities." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value of financial instruments [text block]", "terseLabel": "Schedule of carrying value of the financial instruments" } }, "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [line items]", "terseLabel": "Derivative warrant liabilities" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsTable", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]", "terseLabel": "Disclosure of detailed information about financial instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } } }, "auth_ref": [ "r96", "r98", "r104" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [line items]", "terseLabel": "Financial instruments and financial risk management" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r104" ] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagement", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagements" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "terseLabel": "Financial instruments and financial risk management" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcern", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcerns" ], "lang": { "en-us": { "role": { "label": "Disclosure of general information about financial statements [text block]", "terseLabel": "Nature of operations and going concern" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [text block]", "terseLabel": "Income taxes" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationTables", "http://www.psyence.com/role/DisclosureShareBasedCompensationTabless" ], "lang": { "en-us": { "role": { "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]", "terseLabel": "Summary of fair value of the options was determined at the grant date based on the Black Scholes pricing model, using the following weighted average assumptions" } }, "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options." } } }, "auth_ref": [ "r89" ] }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesTables", "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesTabless" ], "lang": { "en-us": { "role": { "label": "Disclosure of information about key management personnel [text block]", "terseLabel": "Summary of compensation to key management personnel" } }, "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInterestsInSubsidiariesExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationTables", "http://www.psyence.com/role/DisclosureBasisOfPresentationTabless" ], "lang": { "en-us": { "role": { "label": "Disclosure of interests in subsidiaries [text block]", "terseLabel": "Summary of consolidation" } }, "en": { "role": { "documentation": "The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r63" ] }, "ifrs-full_DisclosureOfIssuedCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIssuedCapitalExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureShareCapital" ], "lang": { "en-us": { "role": { "label": "Disclosure of issued capital [text block]", "terseLabel": "Share capital" } }, "en": { "role": { "documentation": "The disclosure of issued capital. [Refer: Issued capital]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureMaterialAccountingPolicies", "http://www.psyence.com/role/DisclosureSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Disclosure of material accounting policy information [text block]", "terseLabel": "Significant accounting policies", "verboseLabel": "Material accounting policies" } }, "en": { "role": { "documentation": "The entire disclosure of material accounting policy information applied by the entity." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract", "lang": { "en-us": { "role": { "label": "Financial instruments and financial risk management" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherOperatingIncomeExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncome" ], "lang": { "en-us": { "role": { "label": "Disclosure of other operating income [text block]", "terseLabel": "Other income" } }, "en": { "role": { "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureTransactionsWithRelatedParties", "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiess" ], "lang": { "en-us": { "role": { "label": "Disclosure of related party [text block]", "terseLabel": "Transactions with related parties" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r41" ] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensation", "http://www.psyence.com/role/DisclosureShareBasedCompensations" ], "lang": { "en-us": { "role": { "label": "Disclosure of share-based payment arrangements [text block]", "terseLabel": "Share based compensation" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r84" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [line items]", "terseLabel": "Investment in subsidiaries" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } } }, "auth_ref": [ "r45", "r47", "r70" ] }, "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of significant unobservable inputs used in fair value measurement of liabilities [text block]", "terseLabel": "Schedule of quantitative information regarding Level 2 fair value measurements of warrants" } }, "en": { "role": { "documentation": "The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items]", "terseLabel": "Quantitative information regarding Level 2 fair value measurements" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesTable", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of significant unobservable inputs used in fair value measurement of liabilities [table]", "terseLabel": "Disclosure of significant unobservable inputs used in fair value measurement of liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to significant unobservable inputs used in the fair value measurement of liabilities." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]", "terseLabel": "Summary of unrecognized deferred tax" } }, "en": { "role": { "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]" } } }, "auth_ref": [ "r29" ] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]", "terseLabel": "Unrecognized deferred tax asset" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } } }, "auth_ref": [ "r29" ] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "lang": { "en-us": { "role": { "label": "Share based compensation" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]", "terseLabel": "Share based compensation" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r87" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "Transactions with related parties" } } }, "auth_ref": [] }, "pbm_DividendYield": { "xbrltype": "percentItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "DividendYield", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Dividend rate.", "label": "Dividend Yield", "terseLabel": "Dividend rate" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r142" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r142" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r143" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.psyence.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r142" ] }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForBusinessCombinationsMember", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for business combinations [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r92", "r93" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails", "http://www.psyence.com/role/DisclosureShareCapitalDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Entity's total for related parties [member]", "terseLabel": "Entity's total for related parties [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r39" ] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss" ], "lang": { "en-us": { "role": { "label": "Entity's total for subsidiaries [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r45", "r47", "r70" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfChangesInNetParentInvestment", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity", "periodEndLabel": "Balance at end", "periodStartLabel": "Opening balance as at beginning", "totalLabel": "NET DEFICIT" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r10", "r16", "r58", "r60", "r71", "r72", "r74" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity [abstract]", "terseLabel": "EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "TOTAL LIABILITIES AND NET DEFICIT" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r10" ] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Equity [member]", "terseLabel": "Equity [member]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r4" ] }, "pbm_ExercisePriceMeasurementInputMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ExercisePriceMeasurementInputMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for exercise price used as a measurement input.", "label": "Exercise Price, Measurement Input [Member]", "terseLabel": "Exercise price" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price, share options granted", "terseLabel": "Exercise price" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r88" ] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected dividend as percentage, share options granted", "terseLabel": "Expected dividend yield" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r88" ] }, "ifrs-full_ExpenseByNatureAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseByNatureAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Expenses by nature [abstract]", "terseLabel": "Expenses" } } }, "auth_ref": [] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "crdr": "debit", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationDetailss" ], "lang": { "en-us": { "role": { "label": "Expense from share-based payment transactions", "terseLabel": "Value of options and restricted stock units granted" } }, "en": { "role": { "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets." } } }, "auth_ref": [ "r91" ] }, "pbm_ExpirationOn2041Member": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ExpirationOn2041Member", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for expiration on 2041.", "label": "Expiration on 2041 [Member]", "terseLabel": "2041" } } }, "auth_ref": [] }, "pbm_ExpirationOn2042Member": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ExpirationOn2042Member", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for expiration on 2042.", "label": "Expiration on 2042 [Member]", "terseLabel": "2042" } } }, "auth_ref": [] }, "pbm_ExpirationOn2043Member": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ExpirationOn2043Member", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for expiration on 2043.", "label": "Expiration on 2043 [Member]", "terseLabel": "2043" } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance costs", "negatedLabel": "Interest expense" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r22" ] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance income", "negatedLabel": "Interest Income", "terseLabel": "Interest income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r150" ] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities", "terseLabel": "Carrying Amount" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r95" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities, at fair value", "terseLabel": "Financial instruments at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r95" ] }, "pbm_FinancialLiabilitiesFairValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "FinancialLiabilitiesFairValuePerShare", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value per share of financial liabilities.", "label": "Financial Liabilities, Fair Value Per Share", "terseLabel": "Fair value per warrant" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities, class [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r102", "r103", "r113", "r114" ] }, "pbm_FinancialLiabilitiesUndiscountedCashFlows": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "FinancialLiabilitiesUndiscountedCashFlows", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of contractual undiscounted cash flows in relation to financial liabilities.", "label": "Financial Liabilities Undiscounted Cash Flows", "terseLabel": "Contractual Cash Flows" } } }, "auth_ref": [] }, "pbm_FirstTrancheNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "FirstTrancheNoteMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for First tranche note.", "label": "First Tranche Note [Member]", "terseLabel": "First Tranche Note" } } }, "auth_ref": [] }, "ifrs-full_ForeignCountriesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ForeignCountriesMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Foreign countries [member]", "terseLabel": "Australia" } }, "en": { "role": { "documentation": "This member stands for countries outside the entity's country of domicile. [Refer: Country of domicile [member]]" } } }, "auth_ref": [ "r110", "r111" ] }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on change in fair value of derivatives", "terseLabel": "Fair value loss" } }, "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r150" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign exchange gain (loss)", "negatedTerseLabel": "Foreign exchange (gain)/loss", "verboseLabel": "Foreign exchange gain" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } } }, "auth_ref": [ "r6", "r32" ] }, "ifrs-full_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "pbm_IfrsOperatingIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative expense", "terseLabel": "General and administrative" } }, "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } } }, "auth_ref": [ "r146" ] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r112", "r122", "r132", "r135" ] }, "ifrs-full_GeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Geographical areas [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r112", "r122", "r132", "r135" ] }, "pbm_HeldInTrustForBrokerageAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "HeldInTrustForBrokerageAccount", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss": { "parentTag": "pbm_CashRestrictedCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetails", "http://www.psyence.com/role/DisclosureCashRestrictedCashAndCashEquivalentsDetailss" ], "lang": { "en-us": { "role": { "documentation": "The amount of held in trust for brokerage account.", "label": "Held in Trust for Brokerage Account", "terseLabel": "Held in trust for brokerage account" } } }, "auth_ref": [] }, "ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HistoricalVolatilityForSharesMeasurementInputMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Historical volatility for shares, measurement input [member]", "terseLabel": "Expected volatility" } }, "en": { "role": { "documentation": "This member stands for the historical volatility for shares used as a measurement input." } } }, "auth_ref": [ "r129" ] }, "pbm_IfrsAccountsPayableAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsAccountsPayableAndAccruedLiabilitiesMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Ifrs Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accounts payable & accrued liabilities" } } }, "auth_ref": [] }, "pbm_IfrsAccountsPayableAndAccruedLiabilitiesTextBlock": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsAccountsPayableAndAccruedLiabilitiesTextBlock", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "pbm_IfrsClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsClassOfWarrantOrRightAxis", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Ifrs Class of Warrant or Right [Axis]" } } }, "auth_ref": [] }, "pbm_IfrsClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsClassOfWarrantOrRightDomain", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Ifrs Class of Warrant or Right [Domain]" } } }, "auth_ref": [] }, "pbm_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Ifrs Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodEndLabel": "Weighted Average Exercise Price per share, Ending", "periodStartLabel": "Weighted Average Exercise Price per share, Beginning", "terseLabel": "Exercise price of warrants per share" } } }, "auth_ref": [] }, "pbm_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Ifrs Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Number of shares issued upon exercise of warrants" } } }, "auth_ref": [] }, "pbm_IfrsConvertibleDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsConvertibleDebtCurrent", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "IFRS Convertible Debt, Current", "verboseLabel": "Convertible note liability" } } }, "auth_ref": [] }, "pbm_IfrsConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsConvertibleDebtMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Ifrs Convertible Debt [Member]", "terseLabel": "Convertible note liability" } } }, "auth_ref": [] }, "pbm_IfrsDebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsDebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "IFRS Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "auth_ref": [] }, "pbm_IfrsFairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsFairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "IFRS Fair Value Adjustment of Warrants", "negatedLabel": "Fair value loss on warrant liability", "terseLabel": "Fair Value loss on derivative warrant" } } }, "auth_ref": [] }, "pbm_IfrsNonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsNonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "IFRS Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other items" } } }, "auth_ref": [] }, "pbm_IfrsOperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsOperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "IFRS Operating Income (Loss)", "totalLabel": "Loss before other items" } } }, "auth_ref": [] }, "pbm_IfrsOtherIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsOtherIncomeAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Other income." } } }, "auth_ref": [] }, "pbm_IfrsProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "IFRS Proceeds from Convertible Debt", "terseLabel": "Proceeds received from convertible note", "verboseLabel": "Total subscription amount" } } }, "auth_ref": [] }, "pbm_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "IFRS Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary of reconciliation of the combined Canadian federal and provincial statutory income tax rate to the effective tax rate" } } }, "auth_ref": [] }, "pbm_IfrsSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsSharePrice", "presentation": [ "http://www.psyence.com/role/DisclosureCriticalAccountingEstimatesAndJudgementsDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "IFRS Share Price", "terseLabel": "Opening trading price", "verboseLabel": "Fair value of the common shares" } } }, "auth_ref": [] }, "pbm_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsStatementLineItems", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "IFRS Statement [Line Items]" } } }, "auth_ref": [] }, "pbm_IfrsStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsStatementTable", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "IFRS Statement [Table]" } } }, "auth_ref": [] }, "pbm_IfrsStockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IfrsStockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "IFRS Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of shares (in shares)" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Condensed Carve out Consolidated Interim Statements of Net Loss and Comprehensive Loss" } } }, "auth_ref": [] }, "pbm_IncomeTaxDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IncomeTaxDisclosureLineItems", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Income Tax Disclosure [Line Items]", "terseLabel": "Income taxes" } } }, "auth_ref": [] }, "pbm_IncomeTaxDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IncomeTaxDisclosureTable", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to income tax disclosures.", "label": "Income Tax Disclosure [Table]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax expense (income)", "totalLabel": "Income tax (recovery)/expense" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r23", "r25", "r26", "r27", "r43", "r69", "r105" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes", "totalLabel": "Change in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r55" ] }, "pbm_IncreaseDecreaseInProfitOrLossDueToReasonablyPossibleChangeInDesignatedRiskComponent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IncreaseDecreaseInProfitOrLossDueToReasonablyPossibleChangeInDesignatedRiskComponent", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetailss" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in profit and loss as a result of an change in a designated risk component that was reasonably possible at the end of the reporting period. Excludes defined benefit plan obligations.", "label": "Increase (Decrease) in Profit or Loss Due To Reasonably Possible Change In Designated Risk Component", "terseLabel": "Impact to profit or loss from fluctuation in foreign exchange rates" } } }, "auth_ref": [] }, "pbm_IncreaseDecreaseInWorkingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "IncreaseDecreaseInWorkingCapitalAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Increase (Decrease) in Working Capital [Abstract]", "terseLabel": "Changes in working capital:" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughOtherContributionsByOwners", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Increase through other contributions by owners, equity", "terseLabel": "Psyence Group contribution" } }, "en": { "role": { "documentation": "The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets other than goodwill [member]", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r51", "r124", "r133" ] }, "ifrs-full_InterestExpenseOnBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnBorrowings", "crdr": "debit", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense on borrowings", "terseLabel": "Interest expense" } }, "en": { "role": { "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]" } } }, "auth_ref": [ "r146" ] }, "ifrs-full_InterestRateMeasurementInputMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestRateMeasurementInputMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest rate, measurement input [member]", "terseLabel": "Risk-free interest rate" } }, "en": { "role": { "documentation": "This member stands for an interest rate used as a measurement input." } } }, "auth_ref": [ "r128" ] }, "pbm_InvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "InvestorsMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for investors.", "label": "Investors [Member]", "terseLabel": "Investors" } } }, "auth_ref": [] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementConsolidatedStatementsOfChangesInNetParentInvestment" ], "lang": { "en-us": { "role": { "label": "Issue of equity", "terseLabel": "Issuance of shares", "verboseLabel": "Net investment by parent in the year" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Issued capital", "terseLabel": "Share Capital" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r120" ] }, "ifrs-full_IssuedCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalAbstract", "lang": { "en-us": { "role": { "label": "Share capital" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]", "terseLabel": "Share Capital" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r4" ] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetails", "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r36" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetails", "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "terseLabel": "Share based compensation" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r35" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetails", "http://www.psyence.com/role/DisclosureTransactionsWithRelatedPartiesKeyManagementPersonnelDetailss" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, short-term employee benefits", "terseLabel": "Short term benefits" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r34" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than three years [member]", "terseLabel": "Between 1 and 3 year" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than three years." } } }, "auth_ref": [ "r138", "r139", "r141" ] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]", "terseLabel": "Level 1" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r31", "r72" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]", "terseLabel": "Level 2" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]", "terseLabel": "Level 3" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]", "terseLabel": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r31", "r72" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r10", "r71", "r72", "r74", "r106", "r109" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities [abstract]", "terseLabel": "LIABILITIES" } } }, "auth_ref": [] }, "pbm_ListingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ListingExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "documentation": "The amount of listing expense.", "label": "Listing Expense", "negatedLabel": "Listing Expense", "totalLabel": "Listing Expense" } } }, "auth_ref": [] }, "pbm_LoanFromRhCapitalFinanceCo.LlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "LoanFromRhCapitalFinanceCo.LlcMember", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Loan from RH Capital Finance Co., LLC.", "label": "Loan From RH Capital Finance Co., LLC [Member]", "terseLabel": "Loan From RH Capital Finance Co., LLC" } } }, "auth_ref": [] }, "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorComponentsOfTaxExpenseIncomeAbstract", "lang": { "en-us": { "role": { "label": "Income taxes" } } }, "auth_ref": [] }, "pbm_MaterialAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "MaterialAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Material accounting policies" } } }, "auth_ref": [] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r12", "r77", "r78", "r79", "r80", "r81", "r82", "r83", "r94", "r101", "r123", "r138" ] }, "pbm_MaximumPercentageOfRebateOnResearchDevelopmentTaxIncentiveProgram": { "xbrltype": "percentItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "MaximumPercentageOfRebateOnResearchDevelopmentTaxIncentiveProgram", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum percentage of rebate for the research & development expenses under the research & development tax incentive program.", "label": "Maximum Percentage Of Rebate On Research & Development Tax Incentive Program", "terseLabel": "Maximum percentage of rebate on eligible research and development expenses" } } }, "auth_ref": [] }, "pbm_MovementsOfNumberOfWarrantsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "MovementsOfNumberOfWarrantsRollForward", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Movements of Number of Warrants [Roll Forward]", "terseLabel": "Number of Warrants" } } }, "auth_ref": [] }, "pbm_MovementsOfWeightedAverageExercisePriceOfWarrantsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "MovementsOfWeightedAverageExercisePriceOfWarrantsRollForward", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Movements of Weighted Average Exercise Price of Warrants [Roll Forward]", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "pbm_NatureOfOperationsAndGoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NatureOfOperationsAndGoingConcernAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Nature of operations and going concern" } } }, "auth_ref": [] }, "pbm_NcacMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NcacMember", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Newcourt Acquisition Corp (NCAC).", "label": "NCAC [Member]", "terseLabel": "NCAC" } } }, "auth_ref": [] }, "pbm_NcacSponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NcacSponsorMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails", "http://www.psyence.com/role/DisclosureShareCapitalDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Newcourt Acquisition Corp (NCAC) Sponsor.", "label": "NCAC Sponsor [Member]", "terseLabel": "NCAC Sponsor" } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Assets (liabilities)", "totalLabel": "Net liabilities acquired" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r126", "r146" ] }, "pbm_NetParentInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NetParentInvestment", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of net parent investment as of balance sheet date.", "label": "Net Parent Investment.", "terseLabel": "Net parent investment" } } }, "auth_ref": [] }, "pbm_NewcourtAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NewcourtAcquisitionCorpMember", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Newcourt Acquisition Corp.", "label": "Newcourt Acquisition Corp [Member]", "terseLabel": "Newcourt Acquisition Corp." } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]", "terseLabel": "Less than 1 year" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r11", "r78", "r79", "r83", "r138", "r141" ] }, "pbm_NotesPayableOnDateOfClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NotesPayableOnDateOfClosingMember", "presentation": [ "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the scenario where notes are payable on the date of closing.", "label": "Notes Payable On The Date Of Closing [Member]", "terseLabel": "Notes payable on the date of closing" } } }, "auth_ref": [] }, "pbm_NotesPayableOnDateOfThatIsOneYearAnniversaryAfterBusinessCombinationOrJanuary252025ClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NotesPayableOnDateOfThatIsOneYearAnniversaryAfterBusinessCombinationOrJanuary252025ClosingMember", "presentation": [ "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the scenario where notes be payable on the date that is the one-year anniversary after the Business Combination, or January 25, 2025.", "label": "Notes Payable On The Date Of That Is The One-Year Anniversary After The Business Combination Or January 25, 2025 Closing [Member]", "terseLabel": "Notes payable on the date that is the one-year anniversary after the Business Combination, or January 25, 2025" } } }, "auth_ref": [] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureOtherIncomeDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Notional amount", "terseLabel": "Notional amount", "verboseLabel": "Principal amount of debt issued" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r146" ] }, "pbm_NumberOfClassesOfWarrantsOutstanding": { "xbrltype": "integerItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfClassesOfWarrantsOutstanding", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of classes of warrants outstanding.", "label": "Number of Classes of Warrants Outstanding", "terseLabel": "Number of classes of warrants outstanding" } } }, "auth_ref": [] }, "pbm_NumberOfDaysPriorToEffectiveInitialRegistrationStatementForFirstResetDate": { "xbrltype": "durationItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfDaysPriorToEffectiveInitialRegistrationStatementForFirstResetDate", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of days prior to effective initial registration statement for first reset date.", "label": "Number of Days Prior to Effective Initial Registration Statement for First Reset Date", "terseLabel": "Number of days prior to effective initial registration statement for first reset date" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Number of instruments granted in share-based payment arrangement", "terseLabel": "Numbers issued" } }, "en": { "role": { "documentation": "The number of instruments granted in share-based payment arrangement." } } }, "auth_ref": [ "r136", "r137" ] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationDetailss" ], "lang": { "en-us": { "role": { "label": "Number of other equity instruments granted in share-based payment arrangement", "terseLabel": "Number of RSUs granted" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r90", "r159" ] }, "pbm_NumberOfSeniorSecuredConvertibleNotesCollectivelyAsNotes": { "xbrltype": "integerItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfSeniorSecuredConvertibleNotesCollectivelyAsNotes", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of senior secured convertible notes collectively called as notes.", "label": "Number of Senior Secured Convertible Notes Collectively as Notes", "terseLabel": "Senior secured convertible notes" } } }, "auth_ref": [] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationDetailss" ], "lang": { "en-us": { "role": { "label": "Number of share options granted in share-based payment arrangement", "terseLabel": "Number of options granted" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://www.psyence.com/role/DisclosureShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r145" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://www.psyence.com/role/DisclosureShareCapitalDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding", "periodEndLabel": "Balance at end (in shares)", "periodStartLabel": "Opening balance as at beginning (in shares)", "terseLabel": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r17" ] }, "pbm_NumberOfTrancheNotes": { "xbrltype": "integerItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfTrancheNotes", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of tranche notes.", "label": "Number of Tranche Notes", "terseLabel": "Number of tranche notes" } } }, "auth_ref": [] }, "pbm_NumberOfWarrantsExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfWarrantsExercisable", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercisable.", "label": "Number of Warrants Exercisable", "terseLabel": "Number of warrants Exercisable" } } }, "auth_ref": [] }, "pbm_NumberOfWarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfWarrantsIssued", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants issued.", "label": "Number of Warrants Issued", "terseLabel": "Number of warrants issued" } } }, "auth_ref": [] }, "pbm_NumberOfWarrantsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "NumberOfWarrantsOutstanding", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants outstanding.", "label": "Number of Warrants Outstanding", "periodEndLabel": "Number of warrants outstanding, Ending", "periodStartLabel": "Number of warrants outstanding, Beginning", "terseLabel": "Number of warrants outstanding" } } }, "auth_ref": [] }, "pbm_OnSecondResetDateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "OnSecondResetDateMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands on the second reset date.", "label": "On the Second Reset Date [Member]", "terseLabel": "On the Second Reset Date" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income", "terseLabel": "Other comprehensive income (loss)" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r2", "r20", "r24", "r67" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income [abstract]", "terseLabel": "Other comprehensive income/(loss)" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations", "terseLabel": "Foreign exchange gain/(loss) on translation" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r15", "r24" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 3.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current receivables", "terseLabel": "Other receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r119" ] }, "ifrs-full_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherIncome", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other income", "terseLabel": "Other income" } }, "en": { "role": { "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r42", "r115", "r116" ] }, "ifrs-full_ParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParentMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementMaturityOfContractualObligationsDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails", "http://www.psyence.com/role/DisclosureShareCapitalDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Parent [member]", "terseLabel": "Psyence Group Inc" } }, "en": { "role": { "documentation": "This member stands for an entity that controls one or more entities." } } }, "auth_ref": [ "r38" ] }, "pbm_PercentageOfReasonablyPossibleChangeInRiskAssumption": { "xbrltype": "percentItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PercentageOfReasonablyPossibleChangeInRiskAssumption", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetailss" ], "lang": { "en-us": { "role": { "documentation": "The reasonably possible percentage of the change in the designated risk component used to determine the value of the financial instrument. Excludes defined benefit plan obligations.", "label": "Percentage of Reasonably Possible Change in Risk Assumption", "terseLabel": "Fluctuation in foreign exchange rates (as a percent)" } } }, "auth_ref": [] }, "pbm_PeriodOfClosingDateConsideredForSecondResetDate": { "xbrltype": "durationItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PeriodOfClosingDateConsideredForSecondResetDate", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The period of closing date considered for second reset date.", "label": "Period of Closing Date Considered for Second Reset Date", "terseLabel": "Period of closing date considered for second reset date" } } }, "auth_ref": [] }, "pbm_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PrivateWarrantsMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for private warrants.", "label": "Private Warrants [Member]", "terseLabel": "Private warrants" } } }, "auth_ref": [] }, "pbm_ProceedsFromContributionsOfParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ProceedsFromContributionsOfParent", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of proceeds from contributions of parent.", "label": "Proceeds From Contributions of Parent", "terseLabel": "Proceeds received from Psyence Group Inc" } } }, "auth_ref": [] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "pbm_IfrsOperatingIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Professional fees and consulting fees" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r146" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetailss", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfCashFlows", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.psyence.com/role/StatementConsolidatedStatementsOfChangesInNetParentInvestment", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Profit (loss)", "negatedTotalLabel": "NET LOSS", "terseLabel": "Net loss", "totalLabel": "NET LOSS", "verboseLabel": "Net loss for the period" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r1", "r19", "r54", "r59", "r61", "r106", "r107", "r127", "r134" ] }, "pbm_PromissoryNotesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PromissoryNotesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Promissory Notes" } } }, "auth_ref": [] }, "pbm_PromissoryNotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PromissoryNotesTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosurePromissoryNotes" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on promissory notes.", "label": "Promissory Notes [Text Block]", "terseLabel": "Promissory Notes" } } }, "auth_ref": [] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary", "terseLabel": "% ownership" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r44", "r46", "r62" ] }, "pbm_PsyenceAustraliaPtyLtd.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PsyenceAustraliaPtyLtd.Member", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Psyence Australia Pty Ltd.", "label": "Psyence Australia Pty Ltd.[Member]", "terseLabel": "Psyence Australia Pty Ltd." } } }, "auth_ref": [] }, "pbm_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PublicWarrantsMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails", "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails", "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for public warrants.", "label": "Public Warrants [Member]", "terseLabel": "Public warrants" } } }, "auth_ref": [] }, "pbm_PysenceBiomedIICorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "PysenceBiomedIICorpMember", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Pysence Biomed II Corp.", "label": "Pysence Biomed II Corp [Member]", "terseLabel": "Pysence Biomed II Corp." } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r76", "r82", "r86", "r130", "r131", "r160" ] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Ranges [member]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r76", "r82", "r86", "r130", "r131", "r160" ] }, "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Reconciliation of accounting profit multiplied by applicable tax rates [abstract]", "terseLabel": "Reconciliation of the combined Canadian federal and provincial statutory income tax rate to the effective tax rate" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfCurrentBorrowings", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Repayments of current borrowings", "terseLabel": "Notes paid" } }, "en": { "role": { "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]" } } }, "auth_ref": [ "r153" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "pbm_IfrsOperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Research and development expense", "terseLabel": "Research and development" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r52" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Reserve of exchange differences on translation", "terseLabel": "Foreign Currency Translation Reserve (OCI)" } }, "en": { "role": { "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r33" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Reserve of exchange differences on translation [member]", "terseLabel": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r33", "r117" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Retained earnings", "terseLabel": "Accumulated Deficit" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r120", "r121" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]", "terseLabel": "Deficit" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r4", "r117" ] }, "ifrs-full_RevenueFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromGovernmentGrants", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureOtherIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Income from government grants", "terseLabel": "Rebate amount of research and development expenses received" } }, "en": { "role": { "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]" } } }, "auth_ref": [ "r151" ] }, "pbm_ReverseTakeoverTransactionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Reverse takeover transaction with NCAC" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionConsiderationPaidAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionConsiderationPaidAbstract", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Reverse Takeover Transaction, Consideration Paid [Abstract]", "terseLabel": "Consideration paid:" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionDeemedConsiderationAmountForCommonSharesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionDeemedConsiderationAmountForCommonSharesIssued", "crdr": "debit", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Deemed consideration amount for the common shares issued", "label": "Reverse Takeover Transaction, Deemed Consideration Amount for Common Shares Issued", "terseLabel": "Deemed consideration amount for the common shares issued" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionNetIdentifiableLiabilityAcquiredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionNetIdentifiableLiabilityAcquiredAbstract", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Reverse Takeover Transaction, Net Identifiable Liability Acquired [Abstract]", "terseLabel": "Net identifiable liability acquired:" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionSharesIssued", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/DisclosureShareCapitalDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued as consideration to shareholders in reverse takeover transaction.", "label": "Reverse Takeover Transaction, Shares Issued", "terseLabel": "Consideration shares issued to NCAC shareholders", "totalLabel": "Total consideration shares issued NCAC shareholders" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionWithNcacAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionWithNcacAxis", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.", "label": "Reverse Takeover Transaction with NCAC [Axis]", "terseLabel": "Reverse Takeover Transaction with NCAC [Axis]" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionWithNcacDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionWithNcacDomain", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for reverse takeover transaction.", "label": "Reverse Takeover Transaction with NCAC [Domain]", "terseLabel": "Reverse Takeover Transaction with NCAC [Domain]" } } }, "auth_ref": [] }, "pbm_ReverseTakeoverTransactionWithNcacTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ReverseTakeoverTransactionWithNcacTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcac" ], "lang": { "en-us": { "role": { "documentation": "Reverse takeover transaction with NCAC", "label": "Reverse Takeover Transaction with NCAC [Text Block]", "terseLabel": "Reverse takeover transaction with NCAC" } } }, "auth_ref": [] }, "ifrs-full_SalesAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SalesAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "pbm_IfrsOperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss", "http://www.psyence.com/role/StatementConsolidatedStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Sales and marketing expense", "terseLabel": "Sales and marketing" } }, "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } } }, "auth_ref": [ "r150" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "auth_ref": [] }, "pbm_ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesTables", "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesTabless" ], "lang": { "en-us": { "role": { "documentation": "Summary of accounts payable and accrued liabilities", "label": "Schedule of Accounts Payable and Accrued Liabilities [Text Block]", "terseLabel": "Summary of accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "pbm_ScheduleOfListingExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ScheduleOfListingExpensesTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of calculation of listing expenses.", "label": "Schedule of Listing Expenses [Table Text Block]", "terseLabel": "Summary of calculation of listing expenses" } } }, "auth_ref": [] }, "pbm_ScheduleOfMaturityAnalysisOfFinancialLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ScheduleOfMaturityAnalysisOfFinancialLiabilitiesTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "documentation": "Thee tabular disclosure of maturity analysis for financial instruments (including derivative and non-derivative instruments) that shows the remaining contractual maturities.", "label": "Schedule Of Maturity Analysis Of Financial Liabilities [Table Text Block]", "terseLabel": "Schedule of maturities of contractual obligations" } } }, "auth_ref": [] }, "pbm_ScheduleOfWarrantTransactionsAndNumberOfWarrantsOutstandingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ScheduleOfWarrantTransactionsAndNumberOfWarrantsOutstandingTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrant transactions and number of warrants outstanding.", "label": "Schedule of Warrant Transactions and Number of Warrants Outstanding [Table Text Block]", "terseLabel": "Summary of warrant transactions and the number of warrants outstanding" } } }, "auth_ref": [] }, "pbm_ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants outstanding and exercisable.", "label": "Schedule of Warrants Outstanding and Exercisable [Table Text Block]", "terseLabel": "Schedule of warrants outstanding and exercisable" } } }, "auth_ref": [] }, "pbm_ShareIssuanceCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ShareIssuanceCostsMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for share issuance costs.", "label": "Share Issuance Costs [Member]", "terseLabel": "Share issuance costs - 20(1)(e)" } } }, "auth_ref": [] }, "pbm_SharePriceMeasurementInputMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "SharePriceMeasurementInputMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for share price used as a measurement input.", "label": "Share Price, Measurement Input [Member]", "terseLabel": "Share price" } } }, "auth_ref": [] }, "pbm_SignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "SignificantAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Significant accounting policies" } } }, "auth_ref": [] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://www.psyence.com/role/DisclosureBasisOfPresentationDetails", "http://www.psyence.com/role/DisclosureBasisOfPresentationDetailss" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r45", "r47", "r70" ] }, "ifrs-full_SignificantUnobservableInputLiabilities": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantUnobservableInputLiabilities", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Significant unobservable input, liabilities", "terseLabel": "Warrants, Measurement input" } }, "en": { "role": { "documentation": "The value of significant unobservable input used in the measurement of the fair value of liabilities." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Condensed Carve out Consolidated Interim Statements of Cash Flows" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "Condensed Carve out Consolidated Interim Statements of Change in Shareholder Equity" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]", "terseLabel": "Condensed Carve out Consolidated Interim Statements of Change in Shareholder Equity" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]", "terseLabel": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r4" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Condensed Carve out Consolidated Interim Statements of Financial Position" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "auth_ref": [] }, "pbm_StockIssuedDuringPeriodSharesIssuedForDebtSettlement": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "StockIssuedDuringPeriodSharesIssuedForDebtSettlement", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "documentation": "Number of stock issued for debt settlement.", "label": "Stock Issued During Period, Shares, Issued for Debt Settlement", "terseLabel": "Issuance of shares for debt settlement (in shares)", "verboseLabel": "Shares issued to settle NCAC liabilities" } } }, "auth_ref": [] }, "pbm_StockIssuedDuringPeriodSharesIssuedForReverseTakeoverTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "StockIssuedDuringPeriodSharesIssuedForReverseTakeoverTransaction", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/DisclosureShareCapitalDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "documentation": "Number of stock issued during the period for reverse takeover transaction.", "label": "Stock Issued During Period, Shares, Issued for Reverse Takeover Transaction", "terseLabel": "Issuance of shares, reverse takeover transaction (in shares)", "verboseLabel": "Shares issued to NCAC shareholders" } } }, "auth_ref": [] }, "pbm_StockIssuedDuringPeriodSharesIssuedToCompensateAdvisors": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "StockIssuedDuringPeriodSharesIssuedToCompensateAdvisors", "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of stock issued to compensate advisors.", "label": "Stock Issued During Period, Shares, Issued to Compensate Advisors", "terseLabel": "Shares issued to compensate advisors" } } }, "auth_ref": [] }, "pbm_StockIssuedDuringPeriodValueIssuedForDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "StockIssuedDuringPeriodValueIssuedForDebtSettlement", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued for settlement of debt.", "label": "Stock Issued During Period, Value, Issued for Debt Settlement", "terseLabel": "Issuance of shares for debt settlement" } } }, "auth_ref": [] }, "pbm_StockIssuedDuringPeriodValueIssuedForReverseTakeoverTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "StockIssuedDuringPeriodValueIssuedForReverseTakeoverTransaction", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued for reverse takeover transaction.", "label": "Stock Issued During Period, Value, Issued for Reverse Takeover Transaction", "terseLabel": "Issuance of shares, reverse takeover transaction" } } }, "auth_ref": [] }, "pbm_SubscriptionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "SubscriptionAmount", "crdr": "credit", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the subscription amounts.", "label": "Subscription Amount", "terseLabel": "Subscription amount" } } }, "auth_ref": [] }, "pbm_SummaryOfNonCapitalIncomeTaxLossesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "SummaryOfNonCapitalIncomeTaxLossesTableTextBlock", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of non-capital income tax losses.", "label": "Summary of Non-capital Income Tax Losses [Table Text Block]", "terseLabel": "Summary of non-capital income tax losses" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectFromChangeInTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectFromChangeInTaxRate", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax effect from change in tax rate", "terseLabel": "Change in tax benefits not recognized" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]" } } }, "auth_ref": [ "r26" ] }, "ifrs-full_TaxEffectOfForeignTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfForeignTaxRates", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax effect of foreign tax rates", "terseLabel": "Difference in tax rates" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } } }, "auth_ref": [ "r26" ] }, "pbm_TaxEffectOfStockBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "TaxEffectOfStockBasedCompensation", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock based compensation.", "label": "Tax Effect of Stock Based Compensation", "terseLabel": "Stock based compensation" } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://www.psyence.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "terseLabel": "Expected income tax (recovery)/expense" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r26" ] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r29" ] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [member]" } }, "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r29" ] }, "pbm_ThereafterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ThereafterMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands after Second Reset Date.", "label": "Thereafter [Member]", "terseLabel": "Thereafter" } } }, "auth_ref": [] }, "pbm_ThirdPartyAdvisorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ThirdPartyAdvisorsMember", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfChangeInShareholderEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for third party advisors.", "label": "Third Party Advisors [Member]", "terseLabel": "Third party advisors" } } }, "auth_ref": [] }, "pbm_ThresholdAmountForMinimumCashCondition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ThresholdAmountForMinimumCashCondition", "crdr": "debit", "presentation": [ "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold amount for minimum cash condition.", "label": "Threshold Amount For Minimum Cash Condition", "terseLabel": "Amount for minimum cash condition" } } }, "auth_ref": [] }, "pbm_ThresholdPeriodForPaymentOfPriceDifferenceBetweenVwapAndConversionPriceInCashOrInShares": { "xbrltype": "durationItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ThresholdPeriodForPaymentOfPriceDifferenceBetweenVwapAndConversionPriceInCashOrInShares", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold period for payment of price difference between VWAP and conversion price in cash or in shares.", "label": "Threshold Period for Payment of Price Difference Between VWAP and Conversion Price in Cash or in Shares", "terseLabel": "Threshold period for payment of price difference between VWAP and conversion price in cash or in shares" } } }, "auth_ref": [] }, "pbm_ThresholdPeriodForVolumeWeightedAveragePrice": { "xbrltype": "durationItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "ThresholdPeriodForVolumeWeightedAveragePrice", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold period for volume-weighted average price.", "label": "Threshold Period for Volume-weighted Average Price", "terseLabel": "Threshold period for volume-weighted average price" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails", "http://www.psyence.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Top of range [member]", "terseLabel": "Maximum" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r76", "r82", "r86", "r130", "r131", "r160" ] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetailss", "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacListingExpensesDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfFinancialPosition", "http://www.psyence.com/role/StatementConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables", "negatedLabel": "Accounts payable and accrued liabilities", "terseLabel": "Accounts payable and accrued liabilities", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r9" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "http://www.psyence.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetailss" ], "lang": { "en-us": { "role": { "label": "Current trade payables", "terseLabel": "Trade payables" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r118", "r149" ] }, "pbm_TransactionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "TransactionExpense", "crdr": "debit", "calculation": { "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.psyence.com/role/DisclosureReverseTakeoverTransactionWithNcacAdditionalInformationDetails", "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "documentation": "The amount of transaction expense.", "label": "Transaction Expense", "negatedLabel": "Transaction Expense", "terseLabel": "Other transaction cost" } } }, "auth_ref": [] }, "ifrs-full_UnobservableInputsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnobservableInputsAxis", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Unobservable inputs [axis]", "terseLabel": "Unobservable inputs [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r73", "r158" ] }, "ifrs-full_UnobservableInputsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnobservableInputsMember", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Unobservable inputs [member]", "terseLabel": "Unobservable inputs [member]" } }, "en": { "role": { "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used." } } }, "auth_ref": [ "r73", "r158" ] }, "pbm_UnsecuredConvertiblePromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "UnsecuredConvertiblePromissoryNotesMember", "presentation": [ "http://www.psyence.com/role/DisclosurePromissoryNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to unsecured convertible promissory note.", "label": "Unsecured Convertible Promissory Notes [Member]", "terseLabel": "Unsecured convertible promissory note" } } }, "auth_ref": [] }, "pbm_UntilFirstResetDateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "UntilFirstResetDateMember", "presentation": [ "http://www.psyence.com/role/DisclosureConvertibleNoteLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for until the First Reset Date.", "label": "Until the First Reset Date [Member]", "terseLabel": "Until the First Reset Date" } } }, "auth_ref": [] }, "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesNonCapitalIncomeTaxLossesDetails" ], "lang": { "en-us": { "role": { "label": "Unused tax losses for which no deferred tax asset recognised", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]" } } }, "auth_ref": [ "r28" ] }, "ifrs-full_UnusedTaxLossesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxLossesMember", "presentation": [ "http://www.psyence.com/role/DisclosureIncomeTaxesUnrecognizedDeferredTaxAssetDetails" ], "lang": { "en-us": { "role": { "label": "Unused tax losses [member]", "terseLabel": "Non-capital losses carried forward" } }, "en": { "role": { "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit." } } }, "auth_ref": [ "r29" ] }, "pbm_WarrantLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "WarrantLiabilitiesMember", "presentation": [ "http://www.psyence.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementCarryingValueOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for warrant liabilities.", "label": "Warrant Liabilities [Member]", "terseLabel": "Derivative warrant liabilities" } } }, "auth_ref": [] }, "pbm_WarrantsIssuedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "WarrantsIssuedNumber", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants issued during the period.", "label": "Warrants Issued, Number", "terseLabel": "Issued" } } }, "auth_ref": [] }, "pbm_WarrantsIssuedOnJanuary252024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "WarrantsIssuedOnJanuary252024Member", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for warrants issued on January 25, 2024.", "label": "Warrants Issued on January 25, 2024 [Member]", "terseLabel": "Issued on January 25, 2024" } } }, "auth_ref": [] }, "pbm_WarrantsIssuedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "WarrantsIssuedWeightedAverageExercisePrice", "presentation": [ "http://www.psyence.com/role/DisclosureDerivativeWarrantLiabilitiesWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price per share or per unit of warrants or rights issued during the period.", "label": "Warrants Issued, Weighted Average Exercise Price", "terseLabel": "Issued, Weighted average exercise price" } } }, "auth_ref": [] }, "pbm_WeightedAverageFairValueOfOptionsGrantedInShareBasedPaymentArrangement": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "WeightedAverageFairValueOfOptionsGrantedInShareBasedPaymentArrangement", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationDetailss" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of options granted in a share-based payment arrangement.", "label": "Weighted Average Fair Value Of Options Granted In Share-based Payment Arrangement", "terseLabel": "Weighted average fair value of options granted (in dollars per share)" } } }, "auth_ref": [] }, "pbm_WeightedAverageFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement": { "xbrltype": "perShareItemType", "nsuri": "http://www.psyence.com/20240131", "localname": "WeightedAverageFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationDetails", "http://www.psyence.com/role/DisclosureShareBasedCompensationDetailss" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of other equity instruments (other than share options) granted in a share-based payment arrangement.", "label": "Weighted Average Fair Value Of Other Equity Instruments Granted In Share-based Payment Arrangement", "terseLabel": "Weighted average fair value of RSUs granted (in dollars per share)" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "presentation": [ "http://www.psyence.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average share price, share options granted", "terseLabel": "Share price" } }, "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } } }, "auth_ref": [ "r88" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://www.psyence.com/role/StatementCondensedCarveOutConsolidatedInterimStatementsOfNetLossAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating basic earnings per share", "terseLabel": "Weighted average number of outstanding shares - basic (in shares)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r50" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_a&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "46", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_46&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "2", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_2_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_d&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "51", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_36&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B36", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B36_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B36_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "IG23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_IG23&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r143": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" } } }